Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Combining negative pressure therapy with platelet-rich plasma speeds up healing and lowers death risk in diabetic foot ulcers.

Eating more fish may lower heart disease risk in women but not in men.

Better patient selection for gastric cancer surgery can reduce complications and improve survival.

Men with better urinary symptoms have a lower risk of death.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Higher doses of 5α-reductase inhibitors reduce mortality risk, while lower doses increase suicide risk.

People with moderate or severe hair loss are at a higher risk of dying from diabetes and heart disease.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

Lower postoperative hematocrit levels increase the risk of death within 28 days after coronary artery bypass surgery.

AI can effectively predict COVID-19 mortality risk using patient data.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Older age and existing health conditions increase COVID-19 death risk.

Type 3 acromegaly patients have more health issues and higher death risk.

Older age and existing health issues increase COVID-19 death risk.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Higher variability in systolic blood pressure increases long-term mortality risk in coronary artery disease patients.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

DHT may increase the risk of heart disease and death in elderly men.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

People with hidradenitis suppurativa have a higher risk of heart attacks and strokes.

Men with early-onset hair loss have a higher risk of metabolic syndrome.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Injecting minced fat into the facial artery can cause severe eye problems and death, more so than other fat types, and larger amounts increase these risks.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.